Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 84

Results For "PLI"

4299 News Found

Lilly expands access to Zepbound weight-loss drug with $299 monthly self-pay option
News | March 17, 2026

Lilly expands access to Zepbound weight-loss drug with $299 monthly self-pay option

The expanded program allows patients to fill prescriptions either at a local pharmacy or through home delivery via LillyDirect


Cupid unveils “Made in India, Japanese Quality” branding to boost global presence
News | March 17, 2026

Cupid unveils “Made in India, Japanese Quality” branding to boost global presence

The initiative comes through a collaboration with Asia’s oldest latex condom manufacturer


First patient dosed in trial of novel drug targeting limb-threatening artery disease
News | March 16, 2026

First patient dosed in trial of novel drug targeting limb-threatening artery disease

The trial will enroll up to 42 patients in Finland across four cohorts


Dr. Jitendra Singh lays Foundation for Rs 600 crore  Orchid Bio-Pharma plant in Kathua
News | March 16, 2026

Dr. Jitendra Singh lays Foundation for Rs 600 crore Orchid Bio-Pharma plant in Kathua

The facility will manufacture the critical antibiotic intermediate Amino Cephalosporanic Acid (ACA), a key component in the production of cephalosporin antibiotics


China’s NMPA approves Zydus-licensed anaemia drug Desidustat
News | March 15, 2026

China’s NMPA approves Zydus-licensed anaemia drug Desidustat

Desidustat tablets are a novel oral HIF-PHI approved for treating anaemia in non-dialysis adult CKD patients


Meiji Seika Pharma launches first-in-human trial of Novel PD-1 agonist for autoimmune diseases
Clinical Trials | March 14, 2026

Meiji Seika Pharma launches first-in-human trial of Novel PD-1 agonist for autoimmune diseases

The early-stage study will test the drug’s safety, tolerability and biological effects in humans


GelMEDIX partners with Catalent to advance vision-restoring cell therapies
News | March 14, 2026

GelMEDIX partners with Catalent to advance vision-restoring cell therapies

The biotechnology company will tap into Catalent’s expertise in induced pluripotent stem cells and advanced cell-therapy manufacturing


Veristat expands global trial & regulatory services as Chinese drugmakers push overseas
Clinical Trials | March 14, 2026

Veristat expands global trial & regulatory services as Chinese drugmakers push overseas

The expansion builds on Veristat’s work helping Chinese pharmaceutical firms such as Hansoh Pharma and CStone Pharmaceuticals


Single-use gloves misused across India, raising health risks
Healthcare | March 14, 2026

Single-use gloves misused across India, raising health risks

One task, one interaction, one pair, experts advocate